BINTRAPDA Trademark

Trademark Overview

On Wednesday, June 14, 2017, a trademark application was filed for BINTRAPDA with the United States Patent and Trademark Office. The USPTO has given the BINTRAPDA trademark a serial number of 79213442. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, July 12, 2024. This trademark is owned by Merck KGaA. The BINTRAPDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use in the field of oncology
bintrapda

General Information

Serial Number79213442
Word MarkBINTRAPDA
Filing DateWednesday, June 14, 2017
Status709 - CANCELLED - SECTION 71
Status DateFriday, July 12, 2024
Registration Number5362196
Registration DateTuesday, December 26, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 10, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use in the field of oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, July 12, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck KGaA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameMerck KGaA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameMerck KGaA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Friday, August 11, 2017APPLICATION FILING RECEIPT MAILED
Thursday, August 3, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, August 4, 2017LIMITATION FROM ORIGINAL APPLICATION ENTERED
Monday, August 7, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 18, 2017ASSIGNED TO EXAMINER
Saturday, August 19, 2017NON-FINAL ACTION WRITTEN
Sunday, August 20, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, August 23, 2017REFUSAL PROCESSED BY MPU
Wednesday, August 23, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, August 25, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 25, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 28, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 8, 2017REFUSAL PROCESSED BY IB
Wednesday, September 20, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 10, 2017PUBLISHED FOR OPPOSITION
Tuesday, October 10, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 26, 2017REGISTERED-PRINCIPAL REGISTER
Monday, March 26, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, April 6, 2018FINAL DISPOSITION NOTICE SENT TO IB
Monday, December 26, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, July 12, 2024CANCELLED SECTION 71
Saturday, May 19, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, August 25, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 25, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 6, 2018FINAL DISPOSITION PROCESSED

Related Keywords

bintrapda oncology field human preparations pharmaceutical